Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: the DECODE-CKD trial : Kidney360

Journal Logo

Original Investigation

Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: the DECODE-CKD trial

Bartholdy, Katja Vua; Johansen, Niklas Dyrbya; Landler, Ninoa; Skaarup, Kristoffer Grundtviga; Jensen, Jespera; Schou, Mortena,c; Christensen, Jacoba; Bressendorff, Iainb; Feldt-Rasmussen, Boc,d; Vaduganathan, Muthiahe; Solomon, Scotte; Haynes, Richardf; Persson, Frederikg; Rossing, Peterf,g; Køber, Larsc,h; Zannad, Faiezi; Hansen, Ditteb,c; Biering-Sørensen, Tora,*

Author Information
Kidney360 ():10.34067/KID.0006982022, December 18, 2022. | DOI: 10.34067/KID.0006982022
  • Open
  • PAP

Abstract

Copyright © 2022 by the American Society of Nephrology